Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction

We examined clinical outcomes with proton pump inhibitors (PPI) use within CYP2C19 genotype groups during clopidogrel treatment following acute myocardial infarction (AMI). 2062 patients were genotyped for CYP2C19*2 and *17 variants in TRIUMPH. 12 month clinical outcomes were analyzed among patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacogenomics J
Main Authors: Depta, Jeremiah P., Lenzini, Petra A., Lanfear, David E., Wang, Tracy Y., Spertus, John A., Bach, Richard G., Cresci, Sharon
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4287459/
https://ncbi.nlm.nih.gov/pubmed/25001880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2014.28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados